Mace Rothenberg – Biography
Last update: April 15, 2026Executive profile
Mace Rothenberg joined Tango Therapeutics in 2008. Mace served as Chief Development Officer, Oncology and Chief Medical Officer for Tango Therapeutics.
Mace Rothenberg is currentlyDirector at Aulos Bioscience - View - Aulos Bioscience org chart
Director at Tango Therapeutics - View - Tango Therapeutics org chart
Independent Board Member at Surrozen - View - Surrozen org chart
Create your alert
to follow the career of Mace Rothenberg.
Education
Mace Rothenberg has a Residency Degree in Internal Medicine from Vanderbilt University in 1985 and a Fellowship in Medical Oncology from National Cancer Institute in 1988.
They have also studied at Vanderbilt University :
Find more alumni from Vanderbilt University
More about Mace Rothenberg
Selected links
Do you need to know more about Mace Rothenberg? More results.
Participate
Social media
- Mace Rothenberg on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mace Rothenberg
The colleagues of Mace Rothenberg
Company Colleagues
- At Aulos Bioscience, Mace Rothenberg has 12 colleagues including Aron Knickerbocker (CEO & Director), Michael Ehlers (Chairman of the Board)…
- At Tango Therapeutics, Mace Rothenberg has 34 colleagues including Malte Peters (CEO), Kanishka Pothula (Director)…
- At Surrozen, Mace Rothenberg has 23 colleagues including Craig Parker (CEO & Director), Mary Haak-Frendscho (Director)…
Industry Colleagues
- In the Biotechnology industry, Mace Rothenberg has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mace Rothenberg.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Mace Rothenberg.
